a-Thalassaemia

EU APPROVES MITAPIVAT | A New Treatment Milestone for Adults with α- or β-Thalassaemia

This decision is of particular importance because it covers a broad adult thalassaemia population, including both alpha- and beta-thalassaemia and both transfusion-dependent and non-transfusion-dependent disease. According to Agios Pharmaceuticals’ official…

Read More »